Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18433300 | IMPLANTABLE MEDICAL SYSTEMS, DEVICES, AND METHODS FOR AFFECTING CARDIAC FUNCTION THROUGH DIAPHRAGM STIMULATION, AND FOR MONITORING DIAPHRAGMATIC HEALTH | February 2024 | March 2025 | Allow | 14 | 1 | 1 | No | No |
| 18418747 | SOMATIC, AUDITORY AND COCHLEAR COMMUNICATION SYSTEM AND METHOD | January 2024 | April 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18530157 | Minimally Invasive Heart Pump with Modular Adjustable Construct Insertion | December 2023 | June 2025 | Allow | 18 | 2 | 1 | No | Yes |
| 18526768 | VAGAL NERVE STIMULATION FOR TREATING CENTRAL NERVOUS SYTEM DISORDERS | December 2023 | September 2024 | Abandon | 10 | 1 | 0 | No | No |
| 18465435 | NEUROSTIMULATION TREATMENT FOR ABNORMAL CONNECTIVITY WITH A CINGULATE REGION | September 2023 | September 2024 | Allow | 12 | 2 | 1 | Yes | No |
| 18226223 | SURGICAL DEVICE TIP WITH DEFLECTABLE JOINT | July 2023 | May 2025 | Allow | 22 | 2 | 0 | No | No |
| 18357532 | NEUROSTIMULATION SYSTEM WITH LINKED PROGRAMMING ADJUSTMENT | July 2023 | March 2025 | Allow | 19 | 2 | 1 | Yes | No |
| 18150746 | Material Characteristics Ideal for Providing Either Partial or Total Mechanical Support to the Failing or Arrested Heart and Method for Developing Ideal Characteristics for Underlying Cardiac Disorders | January 2023 | November 2024 | Allow | 23 | 2 | 1 | No | No |
| 18057863 | SYSTEM AND METHOD FOR CONTROLLING POWER BASED ON IMPEDANCE DETECTION, SUCH AS CONTROLLING POWER TO TISSUE TREATMENT DEVICES | November 2022 | June 2025 | Allow | 31 | 2 | 1 | Yes | No |
| 17939445 | WIRELESS NEUROSTIMULATORS | September 2022 | April 2025 | Allow | 31 | 1 | 1 | Yes | No |
| 17812594 | NONINVASIVE IMAGING AND TREATMENT SYSTEM FOR CARDIAC ARRHYTHMIAS | July 2022 | June 2025 | Allow | 35 | 3 | 0 | No | No |
| 17858668 | MULTIPLE-LEAD IMPLANTABLE SYSTEMS FOR STIMULATION OF CRANIAL NERVES | July 2022 | August 2024 | Allow | 25 | 3 | 1 | Yes | No |
| 17657581 | SOMATIC, AUDITORY AND COCHLEAR COMMUNICATION SYSTEM AND METHOD | March 2022 | September 2023 | Allow | 17 | 1 | 0 | No | No |
| 17646880 | SINGLE CHANNEL AND DUAL CHANNEL NOISE DETECTION SYSTEMS AND TECHNIQUES | January 2022 | September 2023 | Allow | 21 | 2 | 0 | Yes | No |
| 17618097 | Implantable Electrode Lead with Conductors Connected to Form a Braid | December 2021 | September 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17541531 | STIMULATION LEAD AND METHOD INCLUDING A MULTI-DIMENSIONAL ELECTRODE ARRAY | December 2021 | August 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17495595 | METHODS FOR ASSESSING EFFICACY OF RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND DEVICES | October 2021 | November 2024 | Allow | 38 | 4 | 0 | Yes | No |
| 17486072 | WIRELESS NEUROSTIMULATORS | September 2021 | April 2024 | Allow | 31 | 5 | 1 | Yes | Yes |
| 17481510 | VAGAL NERVE STIMULATION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | September 2021 | November 2023 | Allow | 26 | 5 | 1 | No | No |
| 17446730 | IMPLANT DEVICE WITH MEMS (MICROELECTROMECHANICAL SYSTEM) ACTUATED MEMBRANE | September 2021 | June 2025 | Allow | 46 | 3 | 1 | No | No |
| 17461909 | VAGAL NERVE STIMULATION FOR TREATING POST-TRAUMATIC STRESS DISORDER | August 2021 | August 2023 | Allow | 24 | 5 | 1 | Yes | No |
| 17434749 | ALTERNATING CHARGE TO INHIBIT SORPTION TO SURFACES EXPOSED TO BIOLOGICAL MATERIALS | August 2021 | June 2025 | Allow | 45 | 2 | 1 | Yes | No |
| 17346265 | VAGAL NERVE STIMULATION FOR TREATING OR PREVENTING STROKE OR TRANSIENT ISCHEMIC ATTACK | June 2021 | May 2024 | Abandon | 35 | 7 | 1 | No | No |
| 17315895 | Electrically Conductive Coating Applied To An Oxidizable Surface Of An AIMD Ferrule Or Housing To Provide An Oxide-Resistant Connection To An EMI Filter Capacitor, An EMI Filter Circuit Or AIMD Electronic Circuits And Components | May 2021 | April 2024 | Allow | 35 | 4 | 1 | Yes | No |
| 17246782 | SEWING RING WITH QUICK CONNECT TO INFLOW | May 2021 | June 2024 | Allow | 38 | 1 | 1 | Yes | No |
| 17193548 | ALGORITHM FOR DETECTING AND PRESENTING SUCTION IN DOWN-SAMPLED MCS LOG FILES | March 2021 | June 2024 | Allow | 39 | 2 | 1 | Yes | No |
| 17179506 | VEIN OCCLUSION ASSESSMENT USING TEMPERATURE | February 2021 | June 2024 | Allow | 40 | 2 | 1 | Yes | No |
| 17135108 | ELECTRICAL STIMULATION DEVICE AND METHOD | December 2020 | November 2024 | Allow | 46 | 1 | 1 | No | No |
| 17251002 | MICROELECTRODE, PREPARATION METHOD THEREOF AND NEURAL PROSTHESIS | December 2020 | February 2025 | Allow | 51 | 2 | 1 | Yes | No |
| 17247056 | NEURO-CARDIAC GUIDED MAGNETIC STIMULATION THERAPY | November 2020 | April 2024 | Allow | 41 | 2 | 0 | Yes | No |
| 17103035 | MICRO LEAD FOR DIRECTIONAL STIMULATION | November 2020 | September 2024 | Allow | 46 | 4 | 1 | Yes | No |
| 17046687 | MIDFIELD POWER SOURCE FOR WIRELESS IMPLANTED DEVICES | October 2020 | January 2025 | Allow | 51 | 3 | 1 | No | Yes |
| 17029832 | IMPLANTABLE MEDICAL SYSTEMS, DEVICES, AND METHODS FOR AFFECTING CARDIAC FUNCTION THROUGH DIAPHRAGM STIMULATION, AND FOR MONITORING DIAPHRAGMATIC HEALTH | September 2020 | November 2023 | Allow | 38 | 3 | 1 | No | No |
| 17013480 | COGNITIVE SCREENS, MONITOR AND COGNITIVE TREATMENTS TARGETING IMMUNE-MEDIATED AND NEURO-DEGENERATIVE DISORDERS | September 2020 | March 2025 | Allow | 55 | 2 | 1 | No | No |
| 17008058 | IMPLANTABLE STIMULATION LEAD INCLUDING A COILED LEAD BODY AND METHODS FOR FORMING THE SAME | August 2020 | October 2023 | Allow | 37 | 3 | 1 | No | No |
| 16941911 | Biomarker Sampling in the Context of Neuromodulation Devices, Systems, and Methods | July 2020 | June 2024 | Allow | 47 | 3 | 0 | Yes | No |
| 16920876 | IMPLANTABLE LEADLESS PACEMAKERS | July 2020 | December 2023 | Allow | 41 | 2 | 1 | Yes | No |
| 16855080 | SYSTEMS AND METHODS FOR REGULATING ORGAN AND/OR TUMOR GROWTH RATES, FUNCTION, AND/OR DEVELOPMENT | April 2020 | May 2025 | Allow | 60 | 4 | 1 | No | No |
| 16855010 | Sheath Device for Inserting a Catheter | April 2020 | June 2024 | Allow | 50 | 4 | 1 | Yes | No |
| 16796970 | MEDICAL THERAPY ARRANGEMENT FOR APPLYING AN ELECTRICAL STIMULATION TO A HUMAN OR ANIMAL SUBJECT | February 2020 | May 2025 | Allow | 60 | 5 | 1 | No | No |
| 16782141 | IMPLANTABLE ELECTRODE WITH A STUB LINE | February 2020 | September 2023 | Allow | 43 | 4 | 0 | Yes | No |
| 16712501 | PERCUTANEOUS ACCESS FOR SYSTEMS AND METHODS OF TREATING SLEEP-RELATED DISORDERED BREATHING | December 2019 | August 2024 | Allow | 56 | 2 | 1 | No | No |
| 16703603 | WIRELESS ELECTRICAL STIMULATION SYSTEM | December 2019 | June 2024 | Allow | 54 | 6 | 1 | Yes | No |
| 16693088 | VAGAL NERVE STIMULATION TO REDUCE INFLAMMATION ASSOCIATED WITH AN ANEURYSM | November 2019 | September 2024 | Abandon | 58 | 5 | 0 | No | No |
| 16682570 | Optically Excited Biopotential Phantom | November 2019 | April 2024 | Abandon | 53 | 2 | 1 | Yes | No |
| 16525060 | Transvenous Phrenic Nerve Stimulation System | July 2019 | August 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16335047 | OUTPUT CONTROL DEVICE, OUTPUT CONTROL METHOD, AND PROGRAM | March 2019 | August 2024 | Allow | 60 | 6 | 0 | Yes | No |
| 16292144 | NERVE CUFF WITH POCKET FOR LEADLESS STIMULATOR | March 2019 | November 2024 | Allow | 60 | 6 | 1 | No | Yes |
| 16273098 | CATHETER ADAPTED FOR DIRECT TISSUE CONTACT | February 2019 | August 2023 | Allow | 54 | 4 | 1 | No | No |
| 16300361 | THREAD BIDIRECTIONAL INTERLOCKING OF ELECTRODE LEAD | November 2018 | February 2024 | Allow | 60 | 4 | 1 | No | No |
| 16057605 | SYSTEMS AND METHODS FOR APPLYING ANTI-TACHYCARDIA PACING USING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | August 2018 | November 2023 | Allow | 60 | 6 | 0 | Yes | Yes |
| 15805662 | LEADLESS PACEMAKER SYSTEM | November 2017 | June 2024 | Abandon | 60 | 7 | 1 | Yes | Yes |
| 15634842 | ELECTRODE ARRAY ASSEMBLY AND METHOD OF MAKING SAME | June 2017 | November 2023 | Allow | 60 | 5 | 0 | Yes | Yes |
| 15425577 | APPARATUS WITH FILTER TO TREAT MACULAR DEGENERATION AND METHOD OF TREATING MACULAR DEGENERATION | February 2017 | September 2023 | Allow | 60 | 6 | 1 | Yes | No |
| 15412480 | IMPLANTABLE HEART TREATMENT SYSTEMS, DEVICES, AND METHODS | January 2017 | September 2018 | Allow | 20 | 1 | 0 | No | No |
| 14396767 | DEVICE FOR CUTTING HAIR | October 2014 | January 2019 | Allow | 50 | 2 | 1 | Yes | No |
| 14483914 | SYSTEM AND METHOD TO SELECT SIGNAL SEGMENTS FOR ANALYSIS OF A BIOLOGICAL RHYTHM DISORDER | September 2014 | February 2019 | Allow | 53 | 2 | 1 | No | No |
| 13479979 | ESTIMATING ACUTE RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY | May 2012 | November 2013 | Allow | 18 | 2 | 1 | Yes | No |
| 13123402 | METHOD OF FIXATING A HEART HELP DEVICE | April 2011 | April 2016 | Abandon | 60 | 13 | 1 | No | No |
| 12769970 | SCG POINT PICK PROCESS FOR USE WITH MULTIAXIS ACCELEROMETERS | April 2010 | March 2013 | Allow | 35 | 2 | 0 | Yes | No |
| 12448503 | SIGHT REGENERATION ASSISTING DEVICE | March 2010 | May 2012 | Allow | 35 | 2 | 0 | Yes | No |
| 12705262 | SILICONE MOLDED CO-POLYMER COMPOSITE LEAD BODY FOR PACING AND DEFIBRILLATION LEADS | February 2010 | June 2012 | Allow | 28 | 1 | 0 | No | No |
| 11782537 | IMPLANTABLE DEVICE SYSTEM TO COLLECT PARAMETER DATA FOR SERVICE CENTER | July 2007 | October 2009 | Allow | 27 | 1 | 0 | No | No |
| 11733862 | SYSTEM AND METHOD FOR ASSISTED PARTITIONING OF BODY CONDUITS | April 2007 | September 2012 | Allow | 60 | 4 | 1 | No | No |
| 11632866 | PHYSIOLOGICAL SENSOR SYSTEM FOR USE IN A MAGNETIC RESONANCE DEVICE | January 2007 | November 2009 | Allow | 34 | 1 | 0 | No | No |
| 11563296 | HEART STIMULATOR USING A BEZIER FUNCTION TO DEFINE AV-DELAY VALUES | November 2006 | August 2009 | Allow | 33 | 1 | 0 | No | No |
| 11560141 | SYSTEM AND METHOD OF USING REGRESSION MODELS TO ESTIMATE VULNERABLE PERIODS FOR HEART STIMULATION PARAMETERS | November 2006 | August 2009 | Allow | 33 | 1 | 0 | No | No |
| 11599179 | SYSTEMS AND METHODS OF REDUCING ARTIFACT IN NEUROLOGICAL STIMULATION SYSTEMS | November 2006 | June 2012 | Allow | 60 | 6 | 0 | Yes | No |
| 11408773 | CARDIAC PACEMAKER HAVING A SEALED OBLONG HOUSING | April 2006 | June 2011 | Allow | 60 | 3 | 0 | No | No |
| 11378677 | SYSTEM AND METHOD FOR PROVIDING CLOSELY-FOLLOWED CARDIAC THERAPY MANAGEMENT THROUGH AUTOMATED PATIENT CARE | March 2006 | March 2011 | Allow | 60 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BAYS, PAMELA M.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 71.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner BAYS, PAMELA M works in Art Unit 3796 and has examined 68 patent applications in our dataset. With an allowance rate of 89.7%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.
Examiner BAYS, PAMELA M's allowance rate of 89.7% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by BAYS, PAMELA M receive 3.16 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BAYS, PAMELA M is 41 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +10.1% benefit to allowance rate for applications examined by BAYS, PAMELA M. This interview benefit is in the 46% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 24.3% of applications are subsequently allowed. This success rate is in the 26% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 27.6% of cases where such amendments are filed. This entry rate is in the 30% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 133.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 86% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 87.5% of appeals filed. This is in the 79% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 30.0% are granted (fully or in part). This grant rate is in the 22% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 5.9% of allowed cases (in the 91% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.8% of allowed cases (in the 88% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.